Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
BICO Group AB Class B ( (SE:BICO) ) just unveiled an announcement.
BICO Group AB has appointed Lars Risberg as the new General Counsel, succeeding Andréas Joersjö. Risberg brings over 20 years of experience, including his recent role as General Counsel for Vitrolife Group. His expertise in life sciences and international law is expected to enhance BICO’s strategic ambitions in lab automation and life science solutions. This leadership change reflects BICO’s commitment to strengthening its executive team and advancing its market position.
More about BICO Group AB Class B
BICO is a lab automation partner and provider of selected workflows to the pharmaceutical and biotech industries. With over 48,000 instruments installed in more than 65 countries, BICO’s products, software, and solutions are utilized in over 3,500 laboratories, including those of the world’s top 20 pharmaceutical companies. The company operates through two business areas: Lab Automation and Life Science Solutions, aiming to enable and automate future life science labs. BICO is listed on Mid-Cap, Nasdaq Stockholm under BICO.
Average Trading Volume: 175,376
Current Market Cap: SEK2.34B
See more insights into BICO stock on TipRanks’ Stock Analysis page.